ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A.

Brian R Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.